Thomas R. Reeg

Chief Executive Officer (CEO) at Caesars Entertainment Inc

Board

Since N/A

Also at Caesars Entertainment Inc

Bret Yunker

Chief Financial Officer (CFO)

ELQJ

Edmund L. Quatmann Jr.

EVP, Chief Legal Officer, and Secretary

Josh Jones

Chief Marketing Officer (CMO)

About

CEO of CZR since the merger with Eldorado Resorts; brings financial and operational expertise.

$CZR Performance Under Thomas R. Reeg

Past Roles

Organization	Role	Date Range	Details
Eldorado Resorts, Inc.	Chief Executive Officer	January 2019 - July 2020	Held CEO role prior to merger
Eldorado Resorts, Inc.	Chief Financial Officer	March 2016 - May 2019
Eldorado Resorts, Inc.	President	September 2014 - December 31, 2018
Silver Legacy	Member of the Executive Committee	August 2011 - August 2014
Eldorado Resorts LLC	Senior Vice President of Strategic Development	January 2011 - September 2014
Eldorado Resorts LLC	Member of the Board of Managers	December 2007 - September 2014
NGA HoldCo, LLC	Member of the Board of Managers	2007 - 2011
Autocam Corporation	Board of Directors Member	2007 - 2010
AIG Global Investment Group	Managing Director and Portfolio Manager	2002 - 2005	Co-managed high-yield mutual fund portfolios
Bank One Capital Markets	Senior High-Yield Research Analyst	N/A	Covered casino, lodging, and leisure sectors

External Roles

Organization	Role	Date Range	Details
Recreational Enterprises, Inc.	Board of Directors	N/A	Current board membership

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$2,000,000	Annual	Unchanged from 2022 as determined by the Compensation Committee based on competitive market data and internal equity considerations
All Other Compensation	$336,594	Annual	Breakdown: Life Insurance Premiums: $2,352; Long-Term Disability: $1,479; Group Term Life Insurance: $5,382; Use of Corporate or Leased Aircraft: $320,400; 401(k) Match: $6,981; Health Savings Account: $0

Performance Compensation

Data from FY 2023

Non-Equity Incentive Bonus (Cash-Based Award)

Metric	Threshold	Target	Maximum	Actual 2023 Result
Consolidated Adjusted EBITDA ($)	$3,558,600,000	$3,954,000,000	$4,547,100,000	$3,972,000,000 (100.4% of target)
Payout (% of Target)	50%	100%	200%	102.8%
Annual Bonus ($)	$2,000,000	$4,000,000	$8,000,000	$4,112,000 (Bonus Earned)

Performance-Based Adjusted EBITDA (Share-Based Award)

Metric	Value/Details
Performance Threshold	90% of the target goal (50% payout)
Performance Target	100% of the target goal (100% payout)
Performance Maximum	115% of the target goal (200% payout)
Actual Performance	100.4% of target (payout at 102.8% of target)
Grant Date	January 27, 2023
Grant Date Fair Value	$1,791,007
Estimated Award Shares (Threshold)	17,087 shares
Estimated Award Shares (Target)	34,173 shares
Estimated Award Shares (Maximum)	68,346 shares
Vesting Schedule	Three-year performance period; subject to continued employment

Performance-Based rTSR (Relative Total Shareholder Return, Share-Based Award)

Metric	Value/Details
Performance Metric	Relative TSR versus S&P 500
Threshold Performance	35th percentile TSR ranking (50% payout)
Target Performance	50th percentile TSR ranking (100% payout)
Maximum Performance	75th percentile TSR ranking and above (200% payout)
Negative TSR Condition	If 3-year TSR is negative, payout capped at 100%
Grant Date	January 27, 2023
Grant Date Fair Value	$5,253,550
Grant Date Stock Price	$46.88 per share (closing price as of December 31, 2023)
Award Shares (Threshold)	31,732 shares
Award Shares (Target)	63,464 shares
Award Shares (Maximum)	126,928 shares
Vesting Schedule	Vests on January 29, 2026; contingent on continued employment over the 3-year performance period (2023–2025)
Evaluation Period	January 1, 2023 – December 31, 2025

This performance compensation package for 2023 includes multiple components with both cash-based and share-based awards, each tied to specific operational and market performance metrics. The non-equity incentive bonus is based on achieving Adjusted EBITDA targets, while the performance-based awards are linked to Adjusted EBITDA and relative TSR metrics with clearly defined thresholds, targets, maximum levels, grant dates, fair values, and vesting conditions.